Caregen Co.Ltd Cash Flow Conversion Efficiency
Caregen Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Caregen Co.Ltd (214370) has a cash flow conversion efficiency ratio of 0.019x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.16 Billion ≈ $2.82 Million USD) by net assets (₩216.88 Billion ≈ $146.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Caregen Co.Ltd (2015–2024)
Cash flow conversion efficiency of Caregen Co.Ltd from 2015 to 2024. This chart illustrates how Caregen Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Caregen Co.Ltd (214370) stock price for real-time trading data and today's change.
Caregen Co.Ltd Cash Flow Conversion Ratio Explained
Caregen Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Caregen Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Caregen Co.Ltd ranked by their cash flow conversion efficiency. Also see market cap of Caregen Co.Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SEACOR Marine Holdings Inc
NYSE:SMHI
|
-0.061x |
|
MD Pictures Tbk PT
JK:FILM
|
0.025x |
|
HD Renewable Energy Co. Ltd.
TW:6873
|
0.070x |
|
TTFB Co Ltd
TWO:2729
|
0.118x |
|
Bank Multiarta Sentosa PT
JK:MASB
|
0.015x |
|
Quang Viet Enterprise Co Ltd
TW:4438
|
-0.156x |
|
Apator S.A.
WAR:APT
|
0.044x |
|
Roda Vivatex Tbk
JK:RDTX
|
0.003x |
Annual Cash Flow Conversion Efficiency for Caregen Co.Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Caregen Co.Ltd from 2015 to 2024. Review Caregen Co.Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩222.98 Billion ≈ $151.11 Million |
₩13.49 Billion ≈ $9.14 Million |
0.060x | -51.93% |
| 2023-12-31 | ₩227.30 Billion ≈ $154.04 Million |
₩28.60 Billion ≈ $19.38 Million |
0.126x | +198.20% |
| 2022-12-31 | ₩215.98 Billion ≈ $146.37 Million |
₩-27.68 Billion ≈ $-18.76 Million |
-0.128x | -151.82% |
| 2021-12-31 | ₩209.72 Billion ≈ $142.12 Million |
₩51.86 Billion ≈ $35.14 Million |
0.247x | +64.84% |
| 2020-12-31 | ₩205.16 Billion ≈ $139.03 Million |
₩30.78 Billion ≈ $20.86 Million |
0.150x | -53.27% |
| 2019-12-31 | ₩217.01 Billion ≈ $147.06 Million |
₩69.66 Billion ≈ $47.21 Million |
0.321x | +1063.53% |
| 2018-12-31 | ₩204.75 Billion ≈ $138.76 Million |
₩-6.82 Billion ≈ $-4.62 Million |
-0.033x | -116.13% |
| 2017-12-31 | ₩231.83 Billion ≈ $157.11 Million |
₩47.88 Billion ≈ $32.45 Million |
0.207x | +403.39% |
| 2016-12-31 | ₩234.11 Billion ≈ $158.65 Million |
₩-15.94 Billion ≈ $-10.80 Million |
-0.068x | -1180.76% |
| 2015-12-31 | ₩248.87 Billion ≈ $168.66 Million |
₩1.57 Billion ≈ $1.06 Million |
0.006x | -- |
About Caregen Co.Ltd
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG S… Read more